Protagonist Therapeutics, Inc. (PTGX)
96.87
-0.51
(-0.52%)
USD |
NASDAQ |
Jun 08, 15:17
Protagonist Therapeutics Shareholders Equity (Quarterly) : 655.47M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| AbbVie, Inc. | -6.656B |
| Insmed, Inc. | 704.85M |
| Johnson & Johnson | 81.19B |
| Madrigal Pharmaceuticals, Inc. | 543.45M |
| PTC Therapeutics, Inc. | -180.46M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 697.46M |
| Total Liabilities (Quarterly) | 41.99M |
| Debt to Equity Ratio | 0.0149 |
| Current Ratio | 17.76 |
| Net Debt Paydown Yield | 0.00% |